Identification of chronic daily headache risk factors to prevent migraine progression;Prévention des céphalées chroniques quotidiennes

Revue du Praticien

Volumn 58, Issue 6, 2008, Pages 639-642

  Lantéri Minet, Michel ^a  

^a PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; ERGOTAMINE TARTRATE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE;

APNEA; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; HEADACHE; HUMAN; MENTAL DISEASE; MIGRAINE; OBESITY; PATIENT CARE; PRESCRIPTION; REVIEW; RISK FACTOR; SNORING; ARTICLE; CHRONIC DISEASE;

CHRONIC DISEASE; DISEASE PROGRESSION; HEADACHE; HUMANS; RISK FACTORS;

EID: 42149166666     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Lantéri-Minet M, Auray JP, El Hasnaoui A, et al. Prevalence and description of chronic daily headache in the general population in France. Pain 2003;102:143-9.
2. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-9.
3. Katsarava Z, Scneeweiss S, Kurth T, et al. Incidence and predictors for chronocity of headache in patients with episodic migraine. Neurology 2004;62:788-90.
4. Burstein R, Yarnitsky D, Goor-Areyh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614-24.
5. Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001;41:629-37.
6. Cough JR, Lipton RB, Stewart WF, Scher AI. Head and neck injury increases the risk of chronic daily headache: a population-based study. Neurology 2007;69:1169-77.
7. Wilkinson SM, Bahra WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001;41:303-09.
8. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003;43:179-90.
9. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992;327:1109-14.
10. Griffiths RR, Evans SM, Heishman SJ, et al. Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1990;255:1123-32.
11. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004;63:2022-7.
12. Yunus MB, Arslan S, Aldag JC. Relationship between body mass index and fibromyalgia features. Scand J Rheumatol 2002;31:27-31.
13. Webb R, Brammah T, Lunt M, Urwin M, Allison T, Symmons D. Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population. Spine 2003:28:1195-202.
14. Bigal ME, Lieberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006;66:545-50.
15. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic-tension type headache. Neurology 2006;67:252-7.
16. Aldrich MS, Chauncey JB. Are morning headaches part of obstructive sleep apnea syndrome ? Arch Intern Med 1990;150:1265-7.
17. Poceta JS, Dalessio DJ. Identification and treatment of sleep apnea in patients with chronic headache. Headache 1995;35:586-9.
18. Scher AI, Lipton RB, Stewart WF. Habitual snoring as a risk factor for chronic daily headache. Neurology 2003;60:1366-8.
19. Parker RJ, Hardinge M, Jeffries C. Snoring. BMJ 2005;331:1063.
20. Lantéri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 2005;118:319-26.
21. Radat F, Sakh D, Lutz G, El Amrani M, Ferreri M, Bousser MG. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 1999;39:477-80.
22. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.